[en] BACKGROUND: The Inflammatory bowel disease (IBD) Disability Index is a validated tool that evaluates functional status; however, it is used mainly in the clinical trial setting. We describe the use of an iterative Delphi consensus process to develop the IBD Disk-a shortened, self-administered adaption of the validated IBD Disability Index-to give immediate visual representation of patient-reported IBD-related disability. METHODS: In the preparatory phase, the IBD CONNECT group (30 health care professionals) ranked IBD Disability Index items in the perceived order of importance. The Steering Committee then selected 10 items from the IBD Disability Index to take forward for inclusion in the IBD Disk. In the consensus phase, the items were refined and agreed by the IBD Disk Working Group (14 gastroenterologists) using an online iterative Delphi consensus process. Members could also suggest new element(s) or recommend changes to included elements. The final items for the IBD Disk were agreed in February 2016. RESULTS: After 4 rounds of voting, the following 10 items were agreed for inclusion in the IBD Disk: abdominal pain, body image, education and work, emotions, energy, interpersonal interactions, joint pain, regulating defecation, sexual functions, and sleep. All elements, except sexual functions, were included in the validated IBD Disability Index. CONCLUSIONS: The IBD Disk has the potential to be a valuable tool for use at a clinical visit. It can facilitate assessment of inflammatory bowel disease-related disability relevant to both patients and physicians, discussion on specific disability-related issues, and tracking changes in disease burden over time.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Ghosh, Subrata
Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Lönnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life-discovering the true impact. J Crohns Colitis. 2014;8: 1281-1286.
Purc-Stephenson R, Bowlby D, Qaqish ST. "A gift wrapped in barbed wire" positive and negative life changes after being diagnosed with inflammatory bowel disease. Qual Life Res. 2015;24:1197-1205.
Norton C, Dibley LB, Bassett P. Faecal incontinence in inflammatory bowel disease: Associations and effect on quality of life. J Crohns Colitis. 2013;7:e302-e311.
Dibley L, Norton C. Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19:1450-1462.
Wojtowicz AA, Greenley RN, Gumidyala AP, et al. Pain severity and pain catastrophizing predict functional disability in youth with inflammatory bowel disease. J Crohns Colitis. 2014;8:1118-1124.
McDermott E, Mullen G, Moloney J, et al. Body image dissatisfaction: clinical features, and psychosocial disability in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:353-360.
Floyd DN, Langham S, Severac HC, et al. The economic and quality-oflife burden of Crohns disease in Europe and the United States, 2000 to 2013: A systematic review. Dig Dis Sci. 2015;60:299-312.
Cohen BL, Zoega H, Shah SA, et al. Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment Pharmacol Ther. 2014;39: 811-822.
Marin L, Manosa M, Garcia-Planella E, et al. Sexual function and patients perceptions in inflammatory bowel disease: A case-control survey. J Gastroenterol. 2013;48:713-720.
Allen PB, Peyrin-Biroulet L. Moving towards disease modification in inflammatory bowel disease therapy. Curr Opin Gastroenterol. 2013;29: 397-404.
Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1246-1256.
Peyrin-Biroulet L. What is the patients perspective: how important are patient-reported outcomes, quality of life and disability? Dig Dis. 2010; 28:463-471.
Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012;61:241-247.
Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis. 2010;16: 15-22.
Gower-Rousseau C, Sarter H, Savoye G, et al. Validation of the inflammatory bowel disease disability index in a population-based cohort. Gut. [Published online ahead of print December 8, 2015]. doi: 10.1136/gutjnl-2015-310151.
Cieza A, Kirchberger I, Biering-Sorensen F, et al. ICF Core Sets for individuals with spinal cord injury in the long-Term context. Spinal Cord. 2010;48:305-312.
World Health Organization. International Classification of Functioning, Disability and Health. Geneva: World Health Organization; 2001. Available at: http://www.who.int/classifications/icf/en.
Marin-Jimenez I, Nos P, Domenech E, et al. Diagnostic performance of the Simple Clinical Colitis Activity Index self-Administered online at home by patients with ulcerative colitis: CRONICA-UC Study. Am J Gastroenterol. 2016;111:261-268.
Linder D, Sampogna F, Torreggiani A, et al. Psodisk, a new visual method for assessing the burden of psoriasis on patients. J Eur Acad Dermatol Venereol. 2012;26:1163-1166.
Chiricozzi A, Bianchi L, Zangrilli A, et al. Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk. Eur J Dermatol. 2015;25:64-69.
Sampogna F, Linder D, Romano GV, et al. Results of the validation study of the Psodisk instrument, and determination of the cut-off scores for varying degrees of impairment. J Eur Acad Dermatol Venereol. 2015;29:725-731.
Bleich SN, Ozaltin E, Murray CK. How does satisfaction with the healthcare system relate to patient experience? Bull World Health Organ. 2009; 87:271-278.
Prakash B. Patient satisfaction. J Cutan Aesthet Surg. 2010;3:151-155.
Cousin G, Schmid Mast M, Roter DL, et al. Concordance between physician communication style and patient attitudes predicts patient satisfaction. Patient Educ Couns. 2012;87:193-197.
Paddison CA, Abel GA, Roland MO, et al. Drivers of overall satisfaction with primary care: evidence from the english general practice patient survey. Health Expect. 2015;18:1081-1092.
Siegel CA, Lofland JH, Naim A, et al. Novel statistical approach to determine inflammatory bowel disease: patients perspectives on shared decision making. Patient. 2016;9:79-89.
Kennedy AP, Nelson E, Reeves D, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut. 2004; 53:1639-1645.
Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: A randomised controlled trial of the web-guided "Constant-care" approach. Gut. 2010;59:1652-1661.
Selinger CP, Eaden J, Jones DB, et al. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2199-2206.
Greene J, Hibbard JH, Sacks R, et al. When patient activation levels change, health outcomes and costs change, too. Health Aff (Millwood). 2015;34:431-437.
Hibbard JH, Greene J, Shi Y, et al. Taking the long view: how well do patient activation scores predict outcomes four years later? Med Care Res Rev. 2015;72:324-337.
Rubin DT, Siegel CA, Kane SV, et al. Impact of ulcerative colitis from patients and physicians perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009;15:581-588.
Cervesi C, Battistutta S, Martelossi S, et al. Health priorities in adolescents with inflammatory bowel disease: physicians versus patients perspectives. J Pediatr Gastroenterol Nutr. 2013;57:39-42.
Peyrin-Biroulet L, Panes J, Sandborn WJ, et al. Defining disease severity in inflammatory bowel diseases: current and future directions. Clin Gastroenterol Hepatol. 2016;14:348-354.e317.
Bel LG, Vollebregt AM, Van der Meulen-de Jong AE, et al. Sexual dysfunctions in men and women with inflammatory bowel disease: The influence of IBD-related clinical factors and depression on sexual function. J Sex Med. 2015;12:1557-1567.
Ditisheim S, Fournier N, Juillerat P, et al. Inflammatory articular disease in patients with inflammatory bowel disease: result of the Swiss IBD cohort study. Inflamm Bowel Dis. 2015;21:2598-2604.
